Promethazine-Chlorpromazine Combination in the Treatment of Unmanageable Psychotic Patients by Favazza, Armando R.
Henry Ford Hospital Medical Journal
Volume 17 | Number 4 Article 10
12-1969
Promethazine-Chlorpromazine Combination in
the Treatment of Unmanageable Psychotic Patients
Armando R. Favazza
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Chemicals and Drugs Commons, Life Sciences Commons, Medical Specialties
Commons, Psychiatry and Psychology Commons, and the Public Health Commons
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry
Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons.
Recommended Citation
Favazza, Armando R. (1969) "Promethazine-Chlorpromazine Combination in the Treatment of Unmanageable Psychotic Patients,"
Henry Ford Hospital Medical Journal : Vol. 17 : No. 4 , 305-310.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol17/iss4/10
Henry Ford Hosp. Med. Journal 
VoL 17, No. 4, 1969 
Promethazine-chlorpromazine Combination in the 
Treatment of Unmanageable Psychotic Patients 
A r m a n d o R . Favazza, M . D . * 
Administering a combination of promethazine and chlorpromazine to patients with 
a "galloping psychosis" has an antipsychotic and tranquilizing effect which calms 
them down to a more manageable and less aggressive state. The drugs are 
chemically similar; promethazine's actions are strongly potentiated in the combina-
tion, so large doses must be given under careful supervision. Case histories 
demonstrate successful short term management of acutely psychotic, aggressive 
patients who were a danger to themselves and others. 
Acute, intense psychotic episodes 
can pose difficult problems for both 
the patient and those who care for him. 
Use of trifluoperazine may aggravate 
such patients, while thioridazine and 
haloperidol cannot be given parenteral-
ly. Most commonly used drug in treat-
ing such patients is chlorpromazine; 
because of its great ability to calm pa-
tients, its relative safety in large doses, 
its availability in both oral and paren-
teral forms, and also because most 
physicians are familiar with it. 
While most patients can be brought 
under rapid control with chlorproma-
zine alone, there are some who seem 
to resist this treatment. It is not un-
*Department of Psychiatry, Univ. of Mich-
igan. 
Presented at the Resident Education Semi-
nar, Henry Ford Hospital House Staff As-
sociation, May 17, 1969. 
common in the author's experience for 
some patients to receive massive doses 
(up to 3 grams a day) and yet remain 
psychotic and unmanageable. During 
these episodes of "galloping psychosis" 
patients may be abusive to themselves 
and others, unable to follow orders, to 
eat or rest, and frightening to other 
patients. In the past such patients who 
were obviously out of control were 
placed in seclusion rooms and/or 
given electroshock. In many institu-
tions, however, electroshock is not fre-
quently resorted to, and seclusion 
rooms have been abandoned in favor 
of a combination of a better trained 
and more abundant staff, a well con-
ceived milieu, and modern drugs. But 
when the usual drugs and milieu fail, 
even the best trained staff may have 
difficulty handling patients in whom a 
psychotic process rages unabated. For 
such patients the author has found ef-
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fective a combination of promethazine 
(Phenergan) and chlorpromazine. 
The chlorpromazine is used for its 
anti-psychotic and tranquilizing effects. 
Whether chlorpromazine affects symp-
toms alone or has a direct effect on 
some psychotic processes, it appears to 
be beneficial in causing these chaotic 
episodes to abate. The physician cer-
tainly would be remiss to withhold the 
drug or another like it. 
Promethazine, marketed primarily 
as an anti-histaminic, is used because 
of its ability to slow down the patient 
rapidly so that he can be cared for. 
The manufacturer's package insert 
notes that promethazine "relieves ap-
prehension and produces a light sleep 
from which a patient can be easily 
aroused" (the manufacturer specifi-
cally notes this is conjunction with 
nighttime surgical or obstetrical seda-
tion). 
Promethazine is a phenothiazine de-
rivative and is chemically similar to 





Laborit, the French surgeon, at-
tracted great attention to the drug in 
the early 1950's with his papers on its 
use in artificial hibernation.! •'^  The 
drug has also been widely used in sleep 
therapy.* " For psychiatric use prome-
thazine has not been found to be as 
effective as the other phenothiazines^ 
despite some early enthusiasm.'' In 
1958 Shea et aP wrote: 
"The data suggests that promethazine 
unlike other phenothiazine derivatives 
when administered intravenously in 
relatively large concentrations may in-
duce a depression of both cortical and 
subcortical centers. In view of this ac-
tion the drug would seem to have con-
siderable therapeutic value in the man-
agement of those patients with in-
creased psychomotor activity not clin-
ically controlled by either promazine 
or chlorpromazine." 
Promethazine's actions are strongly 
potentiated when administered with 
chlorpromazine. In moderate doses it 
makes a patient feel fatigued or sleepy 
and greatly slows him down. In large 
doses it can put a patient to sleep. It 
is possible to regulate the medication 
so that a patient achieves a light sleep 
from which he can be awakened easily 
to eat, drink, void, breathe deeply and 
take short walks. The state of sleep 
can be so regulated that the patient 
will respond to questions so that the 
progression or diminution of the psy-
chotic episode can be roughly gaged. 
One or two doses of promethazine can 
be withheld if the patient is sleeping 
so deeply as to make evaluation of his 
mental state impossible. Barbituates, 
because of their depressing effect on 
medullary centers and their tendency 
to induce deep sleep, are not satisfac-
tory substitutes for promethazine. 
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Case Reports 
The following cases demonstrate the 
combined use of promethazine and 
chlorpromazine. 
Case Number 1 
The patient was a 17-year-old girl who 
first became psychotic while visiting a for-
eign country as an exchange student. She 
was immediately flown back home and ad-
mitted directly to University Hospital. After 
appearing to restitute, for no discernible 
reason, she became progressively and se-
verely psychotic. For 36 hours she did not 
sit down or eat. She was unable to fol-
low orders. She talked loudly about natural 
and supernatural spirits, the purity of her 
blood, and the secrets of the universe which 
she alone understood. She carried a hair-
brush and hit anyone near her. She rushed 
into the nursing station several times at-
tempting to rip the phone out of the wall. 
The other patients became frightened and 
relayed their anxiety to the staff. As fairly 
standard procedure the patient received 50 
mgs of intramuscular chlorpromazine for 
three doses, 30 minutes apart. This had no 
effect except that she finally agreed to take 
oral medication rather than be held down 
for an injection. She then received hourly 
doses of medication, but seemed unaffected 
by the high dose of 2500 mgs in 24 hours. 
Her blood pressure and physical state were 
closely monitored. Her psychosis appeared 
to worsen. The addition of 20 mgs of tri-
fluoperazine only seemed to heighten her 
agitation. Finally, after 500 mgs of a bar-
bituate was given intramuscularly, the pa-
tient fell asleep. 
In six hours, she awoke, and if anything, 
she was more unmanageable. All attempts 
by staff to handle her failed. Finally she 
was started on a regimen of 50 mgs prome-
thazine orally every four hours and 300 
mgs chlorpromazine orally every four hours. 
The doses were so administered that she 
received one medication or the other every 
two hours. Before each dose her physical 
and mental status were evaluated. She also 
received eight mgs of trihexyphenidyl (Ar-
tane) daily. Within several hours the pa-
tient went into a light sleep. She could be 
aroused easily. She was able to eat and to 
void. With help she could walk to the bath-
room and even brush her teeth. A nursing 
chart was set up and faithfully maintained. 
A typical six-hour period is charted: 
CHART NUMBER ONE 
HOURS 
8 A.M. 9 A.M. 10 A.M. 11 A.M. 1^ Noon 1 P.M. 2 P.M. 
Blood Pressure 110/80 
Chlorpromazine 300 r^ g 
Promettiazine 
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sat in self 
1 l i o i r 
The patient was maintained in this state 
for 10 days. On several occasions she re-
fused to take her medications orally and 
they were then given intramuscularly. Her 
room door was kept open at all times and, 
while other patients could look in, they 
were not allowed to visit. Her treatment 
was discussed at the patient-staff conference. 
A nurse, aide or physician checked the pa-
tient every 30 minutes, and her mental 
status was roughly evaluated by the physi-
cian several times daily. Even while she 
was under the influence of all these medi-
cations, it was possible to determine easily 
at the end of 10 days that her psychosis 
was lessening. Her medication was reduced 
by one-half for a four-day period, then by 
one-half again for four more days. Finally 
the promethazine and trihexyphenidyl were 
eliminated and the patient continued on 
low doses of chlorpromazine. 
Case Number 2 
The patient was a 43-year-old male with 
a long history of mental illness. He had 
received ECT 20 years ago and insulin 
shock therapy six years ago. Eight months 
previously he was diagnosed as a manic-
depressive at a state mental hospital and 
was treated with massive doses of chlor-
promazine (2500 mg a day) for his "mania." 
At this time he was quite paranoid and 
was threatening people with an axe. He 
presented a serious management problem 
for three months until he appeared to "set-
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tie down." Three months after discharge he 
was admitted to the Ann Arbor Veterans 
Hospital where he was diagnosed as having 
a schizo-affective disorder. He was admitted 
by court order after two psychiatrists found 
him to be dangerous to himself and others. 
In the hospital he talked confusedly about 
religion and about wanting to be the presi-
dent of the United States. His son had been 
killed in Vietnam two weeks previously. 
The patient felt that machines were in-
fluencing his mind and that he had to kill 
"some people." He refused to take any medi-
cation. He carried a pool cue and hit sev-
eral patients who tried to talk with him. 
He was forcibly given 100 mg of intra-
muscular chlorpromazine. Four hours later, 
still severely agitated and hostile, he was 
given another 100 mg intramuscularly. 
There was little change in symptoms. He 
raged through most of the night except for 
a few brief naps. 
The next morning he was as hostile as 
ever and struck several patients. He finally 
agreed to take oral medication when told 
he would be given more intramuscular 
medication by force. He was started on 
Q.I.D. oral doses of 200 mg chlorproma-
zine and 75 mg promethazine. After two 
doses he felt somewhat drowsy, and still 
refused to cooperate but did not strike any-
one. That night he was more responsive to 
verbal orders and, while still hostile, was 
more easily approachable. He developed 
mild extra-pyramidal signs and was given 
benztrozine (Cogentin) 2 mg orally B.I.D. 
With each passing day he became easier 
to approach. Two days later he agreed to 
attend group therapy. Within a week he 
was much calmer, cooperative and not very 
aggressive. His medication was reduced to 
chlorpromazine 50 mg and promethazine 50 
mg, both Q.I.D. Four weeks after admis-
sion he was given a two-week leave of ab-
sence on the medication. When he was dis-
charged from the hospital, he continued 
with both drugs. He is being followed in 
the outpatient clinic every two weeks and 
his medication has been continued. There 
has been no evidence of neurological side 
effects. Liver function and other chemical 
tests have been normal. 
Comment 
It must be emphasized that in the 
first case, the medication was not 
given simply to make it easier for the 
staff. She received very close staff con-
siderations after being placed on the 
medication. The medication made it 
possible for the staff to care for the 
patient better and for the patient her-
self to weather her psychosis better. 
Because other patients on the ward 
became apprehensive, and some had 
fantasies about being punished should 
they begin to "act up" keeping the 
door open to the patient's room and 
discussing the treatment at the patient-
staff conference served to allay their 
anxiety. 
In the second case the addition of 
promethazine appeared to decrease the 
patient's ability to act upon his hostile 
feelings. He felt sleepy, groggy and 
weak at times but was able to stay 
awake and eventually engage in sociali-
zation. It should be mentioned that 
(perhaps because of its military associ-
ations) the V. A. hospital milieu gen-
erally serves to decrease aggressive be-
havior in rapid fashion. The patient 
described is well remembered by the 
staff as being an especially difficult pa-
tient in whom chemical restraint was 
a necessity. 
Although combination of prometha-
zine and chlorpromazine has been 
mentioned in the psychiatric literature 
rather infrequently, " the author 
discovered that the combination has 
been used, and is currently being used, 
by psychiatrists at the Ypsilanti State 
Hospital and the Ann Arbor Veterans 
Hospital. In personal communications 
from psychiatrists in those two hos-
pitals, the author was informed that 
the combination is being used for ag-
gressive, difficult to manage psychotic 
patients when chlorpromazine (2000 
mg orally or its equivalent) alone was 
not effective. These psychiatrists re-
ported using the combination also in 
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hospitals in Kansas, Iowa and Europe. 
A check of 10 patient histories, in 
which the combination was mentioned, 
showed that nine patients were ren-
dered more manageable and less ag-
gressive. The usual oral doses of medi-
cation were 200 mgs chlorpromazine 
Q.I.D. and 25 mgs promethazine 
Q.I.D. An anti-parkinsonian drug was 
usually needed. In no patients did liver 
function or other chemical tests be-
come abnormal. 
The doses of both drugs greatly ex-
ceed the doses recommended in the 
manufacturers' direction circulars. 
They must be administered with care. 
The promethazine - chlorpromazine 
combination is evidently in fairly com-
mon use and would appear to be help-
ful in the short term management of 
the acutely psychotic, aggressive pa-
tient. 
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